OOIR: Observatory of International Research

Papers

(The TQCC of Rheumatic Disease Clinics of North America is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)

Article	Citations
Pediatric Rheumatology Comes of Age: Part II	85
Lessons from Cardiac and Vascular Biopsies from Patients with and without Inflammatory Rheumatic Diseases	66
Implementation Science in Pediatric Rheumatology: A Path to Health Equity	46
Copyright	33
Contents	33
Immune Checkpoint Inhibitor-induced Inflammatory Arthritis	27
Advancing Gastrointestinal Microbiota Research in Systemic Sclerosis	24
Molecular Pathways in the Pathogenesis of Systemic Juvenile Idiopathic Arthritis	22
Kawasaki Disease and Multisystem Inflammatory Syndrome in Children	22
Forthcoming Issues	21
Osteoarthritis Treatment Guidelines from Six Professional Societies	21
Exploring the Mucosal Immune Response in Axial Spondyloarthritis Through Immunoglobulin A-Coated Microbiota	20
Impact of Non-steroidal Anti-inflammatory Drugs, Glucocorticoids, and Disease-Modifying Anti-Rheumatic Drugs on Cancer Response to Immune Checkpoint Inhibitor Therapy	19
Copyright	18
COPA Syndrome from Diagnosis to Treatment	18
Contributors	16
Immune Checkpoint Inhibitor-induced Polymyalgia Rheumatica	16
B Cells in Systemic Lupus Erythematosus	15
The Short and Long of COVID-19	14
Venous Thromboembolism in the Inflammatory Rheumatic Diseases	14
Imaging Challenges and Developments in Large-vessel Vasculitis	14
Taxonomy of Quality of Care Indicators	14
Lessons Learned from the COVID-19 Pandemic in Rheumatology	14
Contents	13
Newer Immunosuppressants for Rheumatologic Disease	13

T Cells in Systemic Lupus Erythematosus	13
It Takes Oysters to Generate Pearls	12
Vaccinations in Patients with Rheumatic Disease	12
Multisystem Inflammatory Syndrome in Children and Kawasaki Disease	11
De novo Connective Tissue Disorders as Immune-related Adverse Events	11
Contents	11
Copyright	10
The Utility of Laboratory Investigations for the Assessment and Management of Rheumatic Immune Related Adverse Events	10
Expanding the Treatment Team	10
Uveitis in Children and Adolescents	9
Primary Cardiac Involvement in Systemic Sclerosis	9
Pulmonary Hypertension Associated with Connective Tissue Disease	9
Rheumatology Pearls for the Primary Care Physician	8
Scleroderma: Best Approaches to Patient Care	8
Assessing Patient-Reported Outcomes in Pediatric Rheumatic Diseases	8
Cardiac MRI in Rheumatic Disease	7
Mimickers of Immune Checkpoint Inhibitor-induced Inflammatory Arthritis	7
Daniel J McCarty, MD: A Giant of Rheumatology	7
Clinically Relevant Biomarkers in Connective Tissue Disease-Associated Interstitial Lung Disease	7
COVID-19 and Rheumatology	7
Managing Immunosuppression in Vasculitis Patients in Times of Coronavirus Disease 2019	7
Chronic Nonbacterial Osteomyelitis	6
Guideline Development and Implementation in Rheumatic Disease	6
Imaging of Pulmonary Manifestations of Connective Tissue Disease	6
Contributors	6
Charles L Christian	6
Heart Failure in Rheumatic Disease	6
Contents	6
Preventative Care in Scleroderma	6
Systemic Lupus Erythematosus Classification and Diagnosis	6
Contributors	6
A Guide to Contemporary Clinical Practice Guidelines	6
Imaging of the Major Salivary Glands in Rheumatic Disease	5
Copyright	5
The Impact of Pediatric Rheumatic Diseases on Sexual Health, Family Planning, and Pregnancy	5
Copyright	5
E Carwile LeRoy, MD	5
Antinuclear Antibody Testing for the Diagnosis of Systemic Lupus Erythematosus	5
Forthcoming Issues	5
Biomarkers in Childhood-Onset Systemic Lupus Erythematosus	5
The Giants of Rheumatology at Johns Hopkins: Lawrence E Shulman, MD, PhD and Mary Betty Stevens, MD	5
Contributors	5
The Power of Systems Biology	5
Beyond Coronary Artery Disease	5
Therapeutic Advances in Eosinophilic Granulomatosis with Polyangiitis	4
Environmental Triggers for Rheumatic Disease: From “Why Did I Get This?” to “How Can We Prevent This?”	4
Role of Environment in Pediatric Rheumatic Diseases	4
Copyright	4
CARRA	4
Recommendations for the Use of Nonsteroidal Anti-inflammatory Drugs and Cardiovascular Disease Risk	4

Cardiovascular Comorbidities in Inflammatory Rheumatic Diseases	4
The Role of Psychology in Pediatric Rheumatic Diseases	4
Genetic Defects in Early-Onset Inflammatory Bowel Disease	4
Updates in Systemic Sclerosis Treatment and Applicability to Pediatric Scleroderma	4
Dual-Energy Computed Tomography Applications in Rheumatology	4
Cardiovascular Health in Pediatric Rheumatologic Diseases	4
Cardiovascular Comorbidities in Inflammatory Rheumatic Diseases	4
Patient Engagement in Pediatric Rheumatology Research	4
Treatment Guidelines in Pediatric Rheumatic Diseases	4
SARS-CoV-2 Infection and COVID-19 in Children	4
Management and Cure of Gouty Arthritis	4
Treatment Guidelines in Gout	4